Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications - a retrospective, multicenter ADOReg Study

Haist, M. and Stege, H. and Mohr, P. and Meier, F. and Schadendorf, D. and Ugurel, S. and Livingstone, E. and Zimmer, L. and Herbst, R. and Pföhler, C. and Kähler, K. and Weichenthal, M. and Terheyden, P. and Nashan, D. and Debus, D. and Kaatz, M. and Ziller, F. and Haferkamp, S. and Forschner, A. and Leiter-Stöppke, U. and Kreuter, A. and Ulrich, J. and Kleemann, J. and Grabbe, S. and Loquai, C. (2021) Termination of targeted Therapy with BRAF-/MEK Inhibitors after an initial complete Response in Patients with metastatic Melanoma and its clinical Implications - a retrospective, multicenter ADOReg Study. In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Speech)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Dermatologie und Venerologie
Depositing User: Petra Gürster
Date Deposited: 13 Dec 2022 07:13
Last Modified: 13 Dec 2022 07:13
URI: https://pred.uni-regensburg.de/id/eprint/47909

Actions (login required)

View Item View Item